These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Gastroprotective effect of araloside A on ethanol- and aspirin-induced gastric ulcer in mice: involvement of H He H; Li X; Yu H; Zhu S; He Y; Komatsu K; Guo D; Li X; Wang J; Luo H; Xu D; Zou K J Nat Med; 2019 Mar; 73(2):339-352. PubMed ID: 30523551 [TBL] [Abstract][Full Text] [Related]
44. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor. Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820 [TBL] [Abstract][Full Text] [Related]
45. Reactions of sulfenic acid with 2-mercaptoethanol: a mechanism for the inhibition of gastric (H+-K+)-adenosine triphosphate by omeprazole. Tutunji MF; Qaisi AM; El-Eswed BI; Tutunji LF J Pharm Sci; 2007 Jan; 96(1):196-208. PubMed ID: 16998872 [TBL] [Abstract][Full Text] [Related]
47. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Clissold SP; Campoli-Richards DM Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658 [TBL] [Abstract][Full Text] [Related]
48. Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds. Natale G; Lazzeri G; Lubrano V; Colucci R; Vassalle C; Fornai M; Blandizzi C; Del Tacca M Toxicol Appl Pharmacol; 2004 Feb; 195(1):62-72. PubMed ID: 14962506 [TBL] [Abstract][Full Text] [Related]
49. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo. Reenstra WW; Pinkus LM; Bailey J; Smith WL; Droppleman D; Sancilio LF; Forte JG J Pharmacol Exp Ther; 1992 May; 261(2):737-45. PubMed ID: 1315865 [TBL] [Abstract][Full Text] [Related]
50. Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole. Kinoshita M; Saito N; Noto T; Tamaki H J Pharmacol Exp Ther; 1996 Apr; 277(1):28-33. PubMed ID: 8613931 [TBL] [Abstract][Full Text] [Related]
51. Gastric acid secretion: activation and inhibition. Sachs G; Prinz C; Loo D; Bamberg K; Besancon M; Shin JM Yale J Biol Med; 1994; 67(3-4):81-95. PubMed ID: 7502535 [TBL] [Abstract][Full Text] [Related]
52. Inhibition of partially purified K+/H+-ATPase from guinea-pig isolated and enriched parietal cells by substituted benzimidazoles. Beil W; Sewing KF Br J Pharmacol; 1984 Jul; 82(3):651-7. PubMed ID: 6146367 [TBL] [Abstract][Full Text] [Related]
53. Pharmacological reports about gastroprotective effects of methanolic extract from leaves of Solidago chilensis (Brazilian arnica) and its components quercitrin and afzelin in rodents. de Barros M; Mota da Silva L; Boeing T; Somensi LB; Cury BJ; de Moura Burci L; Santin JR; de Andrade SF; Monache FD; Cechinel-Filho V Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):403-17. PubMed ID: 26758066 [TBL] [Abstract][Full Text] [Related]
54. Studies on the mechanism of action of omeprazole. Keeling DJ; Fallowfield C; Milliner KJ; Tingley SK; Ife RJ; Underwood AH Biochem Pharmacol; 1985 Aug; 34(16):2967-73. PubMed ID: 2992525 [TBL] [Abstract][Full Text] [Related]
55. Effects of the enantiomers of lansoprazole (AG-1749) on (H+ + K+)-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells. Nagaya H; Inatomi N; Nohara A; Satoh H Biochem Pharmacol; 1991 Oct; 42(10):1875-8. PubMed ID: 1660270 [TBL] [Abstract][Full Text] [Related]
56. Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN- on gastric acid secretion. Wallmark B; Jaresten BM; Larsson H; Ryberg B; Brändström A; Fellenius E Am J Physiol; 1983 Jul; 245(1):G64-71. PubMed ID: 6307064 [TBL] [Abstract][Full Text] [Related]
57. Sulfide and sulfoxide derivatives of substituted benzimidazoles inhibit acid formation in isolated gastric glands by different mechanisms. Fryklund J; Wallmark B J Pharmacol Exp Ther; 1986 Jan; 236(1):248-53. PubMed ID: 3001289 [TBL] [Abstract][Full Text] [Related]
58. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist. Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685 [TBL] [Abstract][Full Text] [Related]
59. Histamine and duodenal ulcer: effect of omeprazole on gastric histamine in patients with duodenal ulcer. Man WK; Thompson JN; Baron JH; Spencer J Gut; 1986 Apr; 27(4):418-22. PubMed ID: 2420686 [TBL] [Abstract][Full Text] [Related]
60. Synthesis of 4-(phenylamino)quinoline-3-carboxamides as a novel class of gastric H+/K+-ATPase inhibitors. Uchida M; Otsubo K; Matsubara J; Ohtani T; Morita S; Yamasaki K Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):693-8. PubMed ID: 7600619 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]